Novartis Ag (NVS) EPS (Diluted) (2009 - 2026)
Novartis Ag (NVS) EPS (Diluted) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.28 Bn | 463.71 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 378.50 Bn | 371.36 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 302.91 Bn | 295.22 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 259.04 Bn | 254.14 Bn | 12.86 Bn | 1.61 |
| 6 | Amgen | 237.16 Bn | 223.17 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 183.02 Bn | 179.84 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 160.85 Bn | 149.16 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.85 Bn | 101.69 Bn | 8.24 Bn | 0.28 |
| 10 | Sanofi | 55.18 Bn | 47.80 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 |
| Jun 30, 2025 | 21.42 |
| Dec 31, 2024 | 21.64 |
| Jun 30, 2024 | 20.40 |
| Dec 31, 2023 | 22.31 |
| Sep 30, 2023 | 0.12 |
| Jun 30, 2023 | 24.75 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 27.01 |
| Sep 30, 2022 | 0.11 |
| Jun 30, 2022 | 28.46 |
| Mar 31, 2022 | 15,044.85 |
| Dec 31, 2021 | 29.94 |
| Sep 30, 2021 | 0.62 |
| Jun 30, 2021 | 23.93 |
| Mar 31, 2021 | 6,098.13 |
| Dec 31, 2020 | 24.65 |
| Sep 30, 2020 | 7,813.10 |
| Jun 30, 2020 | 23.36 |
| Mar 31, 2020 | 0.08 |